Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Capricor Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Capricor Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Capricor Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Capricor Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Capricor Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Capricor Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Capricor Therapeutics Acquires Intellectual Property Rights to Natriuretic Peptides from Medtronic 11
Venture Financing 12
Capricor Therapeutics Raises Funds through Venture Financing 12
Partnerships 13
Capricor Therapeutics Enters into Agreement with US Army Institute of Surgical Research 13
Licensing Agreements 14
Capricor Therapeutics Amends Licenses Agreement with Cedars-Sinai Medical for Exosomes 14
Equity Offering 16
Capricor Therapeutics Files Registration Statement to Raise up to USD14 Million in Public Offering of Shares 16
Capricor Therapeutics Plans to Raise up to USD1 Million in Public Offering of Shares 17
Capricor Therapeutics to Raise USD3.7 Million in Private Placement of Shares 18
Capricor Therapeutics Raises USD11 Million in Public Offering of Shares 19
Capricor Therapeutics to Raise USD4 Million in Private Placement of Shares and Warrants 21
Capricor Therapeutics to Raise USD7 Million in Private Placement of Shares 22
Capricor Therapeutics Raises USD10 Million in Private Placement of Common Stock 23
Debt Offering 25
Capricor Therapeutics Raises USD0.4 Million in Private Placement of Note 25
Capricor Therapeutics Inc – Key Competitors 26
Capricor Therapeutics Inc – Key Employees 27
Capricor Therapeutics Inc – Locations And Subsidiaries 28
Head Office 28
Recent Developments 29
Financial Announcements 29
Aug 09, 2018: Capricor Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update 29
May 10, 2018: Capricor Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update 31
Mar 14, 2018: Capricor Presents Fourth Quarter and Full Year 2017 Financial Results and Corporate Update 33
Nov 08, 2017: Capricor Therapeutics Reports Third Quarter 2017 Financial Results and Provides Update on Duchenne Muscular Dystrophy Development Program 35
Aug 10, 2017: Capricor Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update 36
May 15, 2017: Capricor Therapeutics Reports First Quarter 2017 Financial Results and Provides Corporate Update 37
Mar 15, 2017: Capricor Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update 38
Corporate Communications 39
Dec 20, 2017: Capricor Therapeutics: Departure of Directors or Certain Officers; Election of Directors 39
Other Significant Developments 40
Feb 14, 2018: The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41
Capricor Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Capricor Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Capricor Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Capricor Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Capricor Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Capricor Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Capricor Therapeutics Acquires Intellectual Property Rights to Natriuretic Peptides from Medtronic 11
Capricor Therapeutics Raises Funds through Venture Financing 12
Capricor Therapeutics Enters into Agreement with US Army Institute of Surgical Research 13
Capricor Therapeutics Amends Licenses Agreement with Cedars-Sinai Medical for Exosomes 14
Capricor Therapeutics Files Registration Statement to Raise up to USD14 Million in Public Offering of Shares 16
Capricor Therapeutics Plans to Raise up to USD1 Million in Public Offering of Shares 17
Capricor Therapeutics to Raise USD3.7 Million in Private Placement of Shares 18
Capricor Therapeutics Raises USD11 Million in Public Offering of Shares 19
Capricor Therapeutics to Raise USD4 Million in Private Placement of Shares and Warrants 21
Capricor Therapeutics to Raise USD7 Million in Private Placement of Shares 22
Capricor Therapeutics Raises USD10 Million in Private Placement of Common Stock 23
Capricor Therapeutics Raises USD0.4 Million in Private Placement of Note 25
Capricor Therapeutics Inc, Key Competitors 26
Capricor Therapeutics Inc, Key Employees 27
List of Figures
Capricor Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Capricor Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Capricor Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Capricor Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Capricor Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Capricor Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Capricor Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Capricor Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9